UPDATED Jun 13, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
524558 | ₹6,588.50 | 7.3% | 120.0% | ₹81.6b | ₹8,300.00 | PE28.2x | E12.2% | 0.2% | ||
ORCHPHARMA | ₹1,048.70 | -1.5% | 148.4% | ₹53.3b | ₹1,252.33 | PE57.7x | E42.4% | n/a | ||
524742 | ₹1,398.45 | 7.3% | 72.4% | ₹111.1b | ₹1,568.67 | PE23.2x | E11.7% | 0.4% |